Vaccine News and Research

Latest Vaccine News and Research

ETVAX vaccine candidate shows promise against enterotoxigenic E. coli diarrhea

University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.

20 Nov 2019

Vaccination against HIV can be counterproductive if it triggers the wrong type of immune response

A discovery could help immunologists design vaccines that are more effective in protecting against HIV infection.

20 Nov 2019

Oral vaccination with cholera toxin helps counteract age-associated obesity

Here the research team tested a safe and well-established microbe-based immune adjuvant to restore immune homeostasis and counteract inflammation-associated obesity in animal models.

19 Nov 2019

Ketogenic diet wards off flu, study finds

The ketogenic diet has gained immense popularity over the past years because it helps lose weight speedily, with a wide range of health benefits. Similar to the Atkins diet, the ketogenic diet may not only help people shed off extra pounds but also boosting the immune system and warding off flu.

19 Nov 2019

MIT researchers develop method to isolate T cells primed for certain allergies or infections

When your immune system is exposed to a vaccine, an allergen, or an infectious microbe, subsets of T cells that can recognize a foreign intruder leap into action.

19 Nov 2019

Anal cancer diagnoses and death rates have increased dramatically over the last 15 years

Rates of new anal cancer diagnoses and deaths related to human papillomavirus, the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston.

19 Nov 2019

Researchers propose a novel method to underscore the benefits of HPV vaccine

Health campaigns on social media aimed at increasing human papillomavirus (HPV) vaccination may see greater success, according to Drexel University researchers, if they inject a narrative into information-based posts.

19 Nov 2019

The startlingly high cost of the ‘free’ flu shot

In the Byzantine world of health care pricing, most people wouldn't expect that the ubiquitous flu shot could be a prime example of how the system's lack of transparency can lead to disparate costs.

19 Nov 2019

Measles heralds state of emergency in Samoa

All students in Samoa should stay at home, because all schools are closed – this message may bring joy to juvenile hearts but not to those of parents and other adults, who know this is because of the destruction caused by the deadly measles epidemic that is spreading across the Pacific islands.

18 Nov 2019

How HIV self-testing affects diagnosis and behaviour in MSM

Men who have sex with men (MSMs) are among the most high-risk groups for acquiring and transmitting HIV infection. A new study published in the journal JAMA Internal Medicinesays that the rate of detection of new infections is more than doubled when self-testing is available. This could increase access to early treatment and thus interrupt the chain of transmission among MSMs.

18 Nov 2019

Legislation and rising incidence of vaccine preventable diseases – the connection explored

There have been repeated reports of outbreaks of “vaccine-preventable disease” or VPDs across United States over the past few years. A new research letter was published this week in the JAMA Pediatrics. It was titled, “Association of Vaccine-Preventable Disease Incidence With Proposed State Vaccine Exemption Legislation.”

18 Nov 2019

New NIH funding will accelerate progress in TB vaccine development

Seattle Children's Research Institute is one of three recipients of $30 million in first-year-funding provided by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to establish centers for immunology research to accelerate progress in tuberculosis vaccine development.

15 Nov 2019

Study shows link between inflammation and mental sluggishness

Scientists at the University of Birmingham in collaboration with the University of Amsterdam have uncovered a possible explanation for the mental sluggishness that often accompanies illness.

15 Nov 2019

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

15 Nov 2019

Study provides new insights into potential outcomes of Zika virus infection

Using a relevant animal model (pigs), University of Saskatchewan researchers have shown that mild Zika virus infection in fetuses can cause abnormal brain development in apparently healthy young animals.

15 Nov 2019

Newly identified antibody has potential to stop, reverse pulmonary arterial hypertension

Scientists at the University of Sheffield, working in collaboration with drug and vaccine developer Kymab Ltd, Cambridge, have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH).

15 Nov 2019

Four important tips to stay safe and healthy during winter

Colder temperatures, inclement weather, changes in the amount of daylight, and the spread of cold and flu viruses can all have a significant impact on your winter well-being, making it more challenging for you to stay safe and healthy.

15 Nov 2019

Altering malarial parasite genes to prevent malaria

Malaria is a mosquito-borne disease caused by the parasitic organism called Plasmodium, of which there are several types that cause the different kinds of malarial fever. This age-old infection still kills over 400,000 people every year, all over the world. A new study published in the journal Cell on November 14, 2019, shows how a simple tweaking of the genes of this organism could quite conceivably lead to the elimination of this disease altogether.

14 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

Limiting the spread of vaccine-related misinformation in social media

In a year that has seen the largest measles outbreak in the US in more than two decades, the role of social media in giving a platform to unscientific anti-vaccine messages and organizations has become a flashpoint.

14 Nov 2019